Want to join the conversation?
In 4Q15, $TMK decided that the Medicare Part D business met the criteria to be held for sale and is classified as discontinued operations. Management has decided on a plan to sell the Part D business and expect it to be sold before end of FY16.
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.